Massive subretinal hemorrhage and anticoagulant therapy

Area of Science:

• Ophthalmology
• Vascular Biology
• Retinal Diseases

Background:

• Anticoagulant therapy is crucial for preventing thromboembolic events.
• Subretinal hemorrhage can cause significant vision loss.
• Disciform macular degeneration is a common cause of exudative macular disease.

Observation:

• A 66-year-old woman on anticoagulant therapy developed a spontaneous, massive subretinal hemorrhage.
• The hemorrhage resulted in blindness, intractable glaucoma, and eventual enucleation of the affected eye.
• Histopathology indicated the bleeding originated from abnormal vessels within a disciform macular degeneration area.

Findings:

• The patient's anticoagulant therapy likely exacerbated the subretinal hemorrhage.
• The hemorrhage's severity was potentially influenced by the patient's anticoagulation status.
• Bleeding from disciform macular degeneration can be catastrophic in anticoagulated patients.

Implications:

• Careful consideration of anticoagulation is necessary in patients with pre-existing retinal conditions.
• Anticoagulant management may need adjustment in patients with risk factors for hemorrhagic events.
• This case highlights the potential for severe ocular complications when anticoagulation intersects with retinal vascular abnormalities.